Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated... Read more
REVOLUTION Medicines
19 followers
Rigel Pharmaceuticals
5 followers
Biocytogen
5 followers
Bicara Therapeutics
2 followers
BAMF Health
2 followers
Cytek Biosciences
1 follower
Asklepios BioPharmaceutical
2 followers
Alamar Biosciences, Inc.
2 followers
Alloy Therapeutics
2 followers
Biolinq
2 followers
Truveta
5 followers
ProcDNA
1 follower